UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008242
Receipt number R000009723
Scientific Title Evaluation of binding property to tau protein, systemic pharmacokinetics and effective dose of [11C]PBB3
Date of disclosure of the study information 2012/06/30
Last modified on 2012/10/05 15:53:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of binding property to tau protein, systemic pharmacokinetics and effective dose of [11C]PBB3

Acronym

Proper evaluation of [11C]PBB3 as in vivo tau imaging agent

Scientific Title

Evaluation of binding property to tau protein, systemic pharmacokinetics and effective dose of [11C]PBB3

Scientific Title:Acronym

Proper evaluation of [11C]PBB3 as in vivo tau imaging agent

Region

Japan


Condition

Condition

Healthy volunteer and Alzheimer's disease

Classification by specialty

Neurology Psychiatry Radiology
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the binding property to tau protein, systemic pharmacokinetics and effective dose of [11C]PBB3

Basic objectives2

Others

Basic objectives -Others

To evaluate the binding property to tau protein, systemic pharmacokinetics and effective dose of [11C]PBB3

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Quantitative measurement of binding property to tau protein, systemic pharmacokinetics and effective dose in PET

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

PET/MRI/psychological
batteries/neurological examinations

Interventions/Control_2

PET/MRI/psychological
batteries/neurological examinations

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

88 years-old >=

Gender

Male

Key inclusion criteria

[healthy volunteer]
50y.o.<=Age<=88y.o., cognitive normal
subjects without severe physical complication

[Alzheimer's disease (AD)]
50y.o.<=Age<=88y.o., based on J-ADNI core study [Comprehensive Research on Aging and Health, The Ministry of Health Labour and Welfare, (19122701)] except CDR and MMSE, 0.5<=CDR<=2, 12<=MMSE<=26

Key exclusion criteria

1.psychiatric complications such as drug
abuse
2.other organic brain complications such as symptomatic stroke, PD-related disorders and other neurodegenrative diseases
3.severe physical complications
4.subject who has metal such as pacemaker in the body, and cannot perform MRI examination
5.subjects with tattoo
6.subject with claustrophobia who cannot perform MRI examination
7.exclude the patients who are recognized as
inadequate patients by doctors with
resposibility in this study

Target sample size

6


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name hitoshi Shimada

Organization

National Institute of Radiological Sciences

Division name

Molecular Imaging Center

Zip code


Address

4-9-1, Anagawa, Inage-ku, Chiba-shi, Chiba, Japan

TEL

+81-(0)43-206-3025

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

National Institute of Radiological Sciences

Division name

Molecular Imaging Center

Zip code


Address

4-9-1, Anagawa, Inage-ku, Chiba-shi, Chiba, Japan

TEL

+81-(0)43-206-3025

Homepage URL


Email



Sponsor or person

Institute

National Institute of Radiological Sciences

Institute

Department

Personal name



Funding Source

Organization

a consignment expense for Molecular Imaging
Program on "Research Base for PET
diagnosis" from the Ministry of Education,
Culture, Sports, Science and Technology
(MEXT), Japanese Government

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 05 Month 18 Day

Date of IRB


Anticipated trial start date

2012 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 06 Month 25 Day

Last modified on

2012 Year 10 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009723


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name